|
FY2026
12 months to Feb 28, 2026
|
FY2025
12 months to Feb 28, 2025
|
FY2024
12 months to Feb 29, 2024
|
FY2023
12 months to May 31, 2023
|
FY2022
12 months to May 31, 2022
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Cost of revenues | |||||
| Gross loss | |||||
| Operating expenses: | |||||
| Tax and surcharges | |||||
| Selling and marketing expenses | |||||
| General and administrative expenses | |||||
| Research and development expenses | |||||
| Impairment losses | |||||
| Impairment for credit losses | |||||
| Impairment of property, plant and equipment | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income (expenses): | |||||
| Interest income | |||||
| Interest expense | |||||
| Other expense, net | |||||
| Total other income (expenses) | |||||
| Loss before taxes from operations | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Total comprehensive loss attributable to: | |||||
| Owners of the Company | |||||
| Non-controlling interest | |||||
| Other comprehensive income: | |||||
| Foreign currency translation (loss)/income | |||||
| Total comprehensive loss | |||||
| Loss per common share, basic | |||||
| Loss per common share, diluted | |||||
| Weighted average number of common shares outstanding, basic | |||||
| Weighted average number of common shares outstanding, diluted | |||||
| Net loss attributable to : | |||||
| Net loss | |||||
| Non-controlling interest |
Loading...